School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Cibus, Inc. CBUS

Healthcare · Biotechnology

$1.55last close 2026-10-09 · market cap $118.46M · delayed data

Trailing returns

1M-2.52%
3M-18.42%
6M+23.02%
1Y+3.33%
5Y-99.00%

Basis: Adjusted daily closes.

What it does

Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients.

Open CBUS in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies